- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04505527
Variability of Movement on an Altered Inertial Dynamics Task
September 27, 2023 updated by: University of Nebraska
The overall goal of this research is to compare the effects of two different exercise programs on gait function in older adults.
The investigators want to determine if participation in lateral stepping exercise program for six weeks will improve gait functions compared to forward walking exercise program.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
The overall goal of this research is to compare the effects of two different exercise programs on gait function in older adults.
It is expected that improved control of foot placement in the lateral stepping task will transfer to improved control during typical forward walking.
Moreover, it is expected that lateral stepping gait training will have a greater effect on recurrent fallers older adults than on the non-fallers older adults and young adults.
It is also expected that the above beneficial results will be retained in a follow-up test six weeks after completion of the intervention and will result in improvements in common clinical balance tests that are used to assess fall risk.
Therefore, in the current proposal, older adults aged 65 years of age and over are being asked to participate.
Study Type
Interventional
Enrollment (Actual)
15
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Nebraska
-
Omaha, Nebraska, United States, 68182
- University of Nebraska-Omaha, Biomechanics Research Building
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
19 years to 90 years (Adult, Older Adult)
Accepts Healthy Volunteers
Yes
Description
Inclusion Criteria:
Subjects must
- be aged between 19 and 35 for the young adult group
- be over 65 years of age for the older adult groups
- be independently residing in the community
- be able to provide informed consent
- be able to walk independently without an assistive device or 30 minutes in three-minute sections interspersed with rest periods.
The older participants must either have sustained two or more falls in the past year (i.e. Fallers) or not have sustained any falls in the past year (i.e. Non-Fallers).
Exclusion Criteria:
- Neurological disorder or progressive neurologic condition - epilepsy, Alzheimer disease and other dementias, stroke, multiple sclerosis, Parkinson's disease, brain infections, brain tumors.
- Movement disorder - ataxia, dystonia, Huntington's disease, myoclonus, Parkinson disease, progressive supranuclear palsy, Wilson disease.
- History of Cardiovascular events this includes any history of heart problems (such as heart attack, chest pain, or conditions which affect the heart's muscles, valves, or rhythm)
- Current injury or moderate to severe pain affecting the lower limbs, pelvis, back, trunk.
- Surgery within the past 6 months.
- Current participation in any other study that involves walking, balance, or training.
Medications will not prevent inclusion in the study however they will be recorded to enable consideration in subsequent post-hoc analyses.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Active Comparator: Recurrent fallers - control group
In this control arm, older adults will have a typical forward walking training that mirror the lateral stepping intervention: 3 days/week for 6 weeks, resulting in a total of eighteen sessions.
Each session consists of six trials of 3 min forward walking.
The participants can increase their pace at the start of each trial but may not decrease it at the next session.
|
Subjects will have a typical forward walking
Other Names:
|
Experimental: Recurrent fallers - intervention group
In this experimental arm, older adults will have a lateral stepping intervention: 3 days/week for 6 weeks, resulting in a total of eighteen sessions.
Each session consists of six trials of 3 min sideways walking across a 10 m walkway changing body direction at the ends, thus alternating lead and lag limbs.
The participants can increase their pace at the start of each trial but may not decrease it at the next session.
|
Subjects will step laterally, changing direction every 10 m, thus alternating lead and lag limbs.
Other Names:
|
Experimental: Older non-fallers intervention group
In this experimental arm, older adults will have a lateral stepping intervention: 3 days/week for 6 weeks, resulting in a total of eighteen sessions.
Each session consists of six trials of 3 min sideways walking across a 10 m walkway changing body direction at the ends, thus alternating lead and lag limbs.
The participants can increase their pace at the start of each trial but may not decrease it at the next session.
|
Subjects will step laterally, changing direction every 10 m, thus alternating lead and lag limbs.
Other Names:
|
Active Comparator: Younger adult control group
Outcome measures from a young healthy group will also be measured as a reference.
Will be used to compare outcome measured between older and young adults.
Young adults will have a lateral stepping intervention: 3 days/week for 6 weeks, resulting in a total of eighteen sessions.
Each session consists of six trials of 3 min sideways walking across a 10 m walkway changing body direction at the ends, thus alternating lead and lag limbs.
The participants can increase their pace at the start of each trial but may not decrease it at the next session.
|
Subjects will step laterally, changing direction every 10 m, thus alternating lead and lag limbs.
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Step width variability
Time Frame: Baseline and Post-Intervention: immediate, and 6 weeks after the completion of the intervention
|
The standard deviation of step width.
Step width was measured as the mediolateral distance between the locations of the sequential left and right heel strikes
|
Baseline and Post-Intervention: immediate, and 6 weeks after the completion of the intervention
|
Step length variability
Time Frame: Baseline and Post-Intervention: immediate, and 6 weeks after the completion of the intervention
|
The standard deviation of step length.
Step length was measured as the anteroposterior distance between the locations of the sequential left and right heel strikes.
|
Baseline and Post-Intervention: immediate, and 6 weeks after the completion of the intervention
|
Swing time variability
Time Frame: Baseline and Post-Intervention: immediate, and 6 weeks after the completion of the intervention
|
The standard deviation of swing time.
Swing time was measured as the time elapse during the swing phase of a leg.
|
Baseline and Post-Intervention: immediate, and 6 weeks after the completion of the intervention
|
Stride time variability
Time Frame: Baseline and Post-Intervention: immediate, and 6 weeks after the completion of the intervention
|
The standard deviation of stride time.
Stride time was measured as the time between 2 consecutive ipsilateral heel strikes.
|
Baseline and Post-Intervention: immediate, and 6 weeks after the completion of the intervention
|
Stance time variability
Time Frame: Baseline and Post-Intervention: immediate, and 6 weeks after the completion of the intervention
|
The standard deviation of stance time.
Stance time was measured as the time elapse during the stance phase of a leg.
|
Baseline and Post-Intervention: immediate, and 6 weeks after the completion of the intervention
|
Timed-Up-and-Go (TUG)
Time Frame: Baseline and Post-Intervention: immediate, and 6 weeks after the completion of the intervention
|
The Timed-Up-and-Go test is used to assess mobility in older adults.
It measures the time to get up from chair, walk 3 m, turn around, walk back, and sit down
|
Baseline and Post-Intervention: immediate, and 6 weeks after the completion of the intervention
|
Berg Balance Test (BBS)
Time Frame: Baseline and Post-Intervention: immediate, and 6 weeks after the completion of the intervention
|
The Berg Balance Test (14 items, max score: 56) is used to measure the functional balance in older adults.
It consists of 14 tasks performed in a standardized order with each task scored on a five-point scale according to quality or time ranging from "0" (lowest level of function) to "4" (highest level).
|
Baseline and Post-Intervention: immediate, and 6 weeks after the completion of the intervention
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Walking speed
Time Frame: Baseline and Post-Intervention: immediate, and 6 weeks after the completion of the intervention
|
Self-selected forward walking and sideways walking speed
|
Baseline and Post-Intervention: immediate, and 6 weeks after the completion of the intervention
|
Falls Efficacy Scale-International (FES-I)
Time Frame: Baseline and Post-Intervention: immediate, and 6 weeks after the completion of the intervention
|
The Falls Efficacy Scale-International (FES-I) questionnaire (16 items, max score: 64) is used to assess confidence in the performance of activities relevant to daily life.
Participants rate 16 individual activities on a scale from 1 (not at all concerned) to 4 (very concerned).
|
Baseline and Post-Intervention: immediate, and 6 weeks after the completion of the intervention
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Brief Pain Inventory - short form (BPI)
Time Frame: Baseline and Post-Intervention: immediate, and 6 weeks after the completion of the intervention
|
The short form of Brief Pain Inventory score (BPI) (4 Pain severity items, max score: 40; 7 Pain interference items, max score: 70) is used to measure the impact of pain on daily functions.
Higher score suggests higher pain intensity (severity), and/or higher impact of pain on functioning (interference).
|
Baseline and Post-Intervention: immediate, and 6 weeks after the completion of the intervention
|
Mini-Mental State Examination (MMSE)
Time Frame: Baseline and Post-Intervention: immediate, and 6 weeks after the completion of the intervention
|
The Mini-Mental State Examination (MMSE) (11 items, max score: 30) is used to measure cognitive impairment.
It consists of 11 questions grouped into 7 cognitive tasks.
A score of 30 suggests no presence of cognitive impairment.
|
Baseline and Post-Intervention: immediate, and 6 weeks after the completion of the intervention
|
Geriatric Depression Scale - short form (GDS)
Time Frame: Baseline and Post-Intervention: immediate, and 6 weeks after the completion of the intervention
|
The Geriatric Depression Scale - short form (GDS) (15 items, max score: 15) is used to measure self-rated depressive symptoms of depression.
A score of 5 or more suggests depression.
|
Baseline and Post-Intervention: immediate, and 6 weeks after the completion of the intervention
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Investigators
- Principal Investigator: Andreas Skiadopoulos, PhD, Research Associate
- Study Director: Nicholas Stergiou, PhD, Assistant Dean
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
November 28, 2017
Primary Completion (Actual)
May 5, 2018
Study Completion (Actual)
May 5, 2021
Study Registration Dates
First Submitted
August 2, 2020
First Submitted That Met QC Criteria
August 5, 2020
First Posted (Actual)
August 10, 2020
Study Record Updates
Last Update Posted (Actual)
September 29, 2023
Last Update Submitted That Met QC Criteria
September 27, 2023
Last Verified
September 1, 2023
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- 0448-16-FB
- P20GM109090 (U.S. NIH Grant/Contract)
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Older Adults
-
KU LeuvenCompletedHealthy Older Adults | Ill Older AdultsBelgium
-
Georgia Institute of TechnologyUniversity of FloridaNot yet recruiting
-
University of GuelphOntario Bean GrowersRecruiting
-
University of JordanRecruiting
-
University of Illinois at ChicagoNational Institute on Aging (NIA)Recruiting
-
University of BathCompletedOlder AdultsUnited Kingdom
-
University of JaenCompletedOlder AdultsColombia
-
Metabolic Technologies Inc.National Institute on Aging (NIA); Vanderbilt UniversityCompleted
-
Riphah International UniversityCompleted
-
East Carolina UniversityCompleted
Clinical Trials on Forward walking
-
Medical University of SilesiaCompleted
-
Bandırma Onyedi Eylül UniversityRecruiting
-
Wayne State UniversityRecruitingMultiple Sclerosis | Gait Disorders, Neurologic | Accidental FallUnited States
-
Ayşe ToramanRecruiting
-
Majmaah UniversityUnknownChronic StrokeSaudi Arabia
-
Dow University of Health SciencesRecruitingKnee Osteoarthritis | Osteo Arthritis Knee | OA KneePakistan
-
Istanbul Medipol University HospitalCompleted
-
University of North Carolina, Chapel HillNational Institute of Allergy and Infectious Diseases (NIAID)Recruiting
-
VA Office of Research and DevelopmentCompletedWell-being | Problem-solving | Peer Support | Online Mental Health ProgramUnited States
-
Hospital for Special Surgery, New YorkRecruitingComplex Regional Pain SyndromesUnited States